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Relative effects of PTH and dietary phosphorus on calcitriol production
in normal and azotemic rats. In moderate renal failure, the serum
calcitriol level is influenced by the stimulatory effect of high PTH and the
inhibitory action of phosphorus retention. Our goal was to evaluate the
relative effect that high PTH levels and increased dietary phosphorus had
on calcitriol production in normal rats (N) and rats with moderate renal
failure (Nx). Normal and Nx (3/4 nephrectomy) rats were divided into two
groups: (1) rats with intact parathyroid glands (IPTG) and (2) parathy-
roidectomized rats in which PTH was replaced (PTHR) by the continuous
infusion of rat 1—34 PTH, 0.022 rg/hr/100 g body wt, using a miniosmotic
Alzet pump. To test the effect of dietary phosphorus, rats received either
a moderate (MPD, 0.6% P) or a high phosphorus (HPD, 1.2%) diet for 14
days. The experimental design included pair-fed N and Nx rats with either
IPTG or PTHR. Serum calcitriol and PTH levels in N rats fed a MPD
were 69 3 and 40 5 pg/mI, respectively. In Nx rats on a MPD, serum
calcitriol levels decreased only if hyperparathyroidism was not allowed to
occur (76 4 vs. 62 4 pg/mI in Nx-IPTG-MPD and Nx-PTHR-MPD
groups respectively, P < 0.05). Even in N rats on a HPD, high PTH levels
(67 8 pglml in the N-IPTG-HPD group) were required to maintain
normal serum calcitriol levels (69 4 vs. 56 6 pg/mI in Nx-IPTG-HPD
and Nx-PTHR-HPD groups, respectively; P < 0.05). In Nx rats on a HPD,
the development of secondary hyperparathyroidism (286 19 pg/mI in the
Nx-IPTG-HPD group) prevented a decrease in serum calcitriol levels (68
7 pg/mI). In contrast, serum calcitriol levels were low in the Nx-PTHR-
HPD group (52 4 pg/mI, P < 0.05), which were deprived of the
adaptative increase in endogenous PTH production. In conclusion, our
results in rats indicate that in moderate renal failure, an elevated FTH
level maintains calcitriol production and overcomes the inhibitory action
of phosphorus retention.
Calcitriol is synthesized in renal tubular cells from its precursor
25(OH)D1, and this process is controlled by the action of the
enzyme 25(OH)D3-1 cs-hydroxylase. In normal humans and ani-
mals phosphorus restriction stimulates the renal production of
calcitriol [1—13], and this effect of phosphorus restriction is even
observed in moderate renal failure [6—11]. Conversely, high
dietary phosphorus has been shown to decrease serum calcitriol
[6—9]. Renal production of calcitriol is also stimulated by para-
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thyroid hormone (PTH) in both normal humans and patients with
moderate renal failure [10, 14—16]. However, the stimulatory
effect of PTH on calcitriol production is greater in normal humans
than in patients with moderate renal failure, presumably due to a
decrease in functional renal mass. Nevertheless, the remnant
renal mass in moderate renal failure appears to be sufficient to
increase calcitriol production [8, 16—18]. In moderate renal
failure, calcitriol levels appear to be influenced by the opposing
effects of phosphorus loading and elevated PTH levels.
It is widely accepted that a deficiency of calcitriol is an
important factor in the development of the secondary hyperpara-
thyroidism of renal failure [8, 11, 19, 20]; however, not every
patient with moderate renal failure has a low calcitriol level [9, 16,
19, 21—24]. Similarly, studies in rats with mild renal failure
receiving a moderate phosphorus diet have shown that secondary
hyperparathyroidism develops even though the serum calcitriol
level is not decreased [8]. In these rats, the stimulatory effect of
increased PTH on calcitriol production may compensate for the
inhibitory effect of an increased phosphorus load and the reduc-
tion in renal mass.
In the present study, the effect that changes in dietary phos-
phorus and PTH have on calcitriol production was evaluated in
normal rats and rats with moderate renal failure. In both normal
and azotemic rats, it was possible to maintain constant, normal
PTH levels in subgroups of rats by performing a parathyroidec-
tomy and then infusing a normal replacement dose of PTH via a
subcutaneously implanted miniosmotic pump. The goal of the
present study was to evaluate in normal rats and in rats with
moderate renal failure, the separate effects that changes in PTH
and dietary phosphorus have on calcitriol production.
Methods
This study was performed in male Wistar rats weighing 150 to
180 grams. Before the start of the study diets, rats were main-
tained on a diet containing 0.6% phosphorus, 0.6% calcium and
100 IU/100 g vitamin D. The experiments included sham-operated
rats (N) and rats with surgically induced renal failure (Nx).
Normal and Nx rats were divided into two groups: (1) rats with
intact parathyroid glands (IPTG) and (2) parathyroidectomized
(PTX) rats which received PTH replacement (PTHR) by the
continuous infusion of rat 1—34 PTH via a minisomotic pump
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(Model 2002, Alza, Palo Alto, CA, USA). To determine the effect
of dietary phosphorus, rats from each group received either a
moderate (0.6%) phosphorus diet (MPD) or a high (1.2%)
phosphorus diet (HPD) with similar calcium content (0.6%).
For all surgical procedures, rats were anesthetized with a
mixture of xylazine chlorhydrate (Rompum, Bayer AG, Le-
verkusen, Germany), 0.1 mg/lOU g body wt, and ketamine chlor-
hydrate (Ketolar, Parke-Davis, Barcelona, Spain), 0.7 mg/lOU g
body wt, administered intramuscularly. Renal failure was surgi-
cally induced by performing selective ligation of arteries in the left
kidney, followed one week later by contralateral nephrectomy. In
the Nx rats, the goal was to induce moderate renal failure, which
in our previous studies has been equated with a serum creatinine
of 0.5 to 0.6 mg/dl [7, 8]; results from these earlier studies have
also shown that at this serum creatinine level, changes in PTH and
phosphorus are capable of modulating serum calcitriol. Selective
parathyroidectomy (PTX) was performed under a dissecting
microscope before the induction of renal failure. After PTX, rats
were placed on a MPD and only rats with serum calcium levels
below 7 mgldl three days after PTX were included in the study.
Once successful PTX was confirmed, normal PTH activity was
restored by the continuous infusion of rat 1—34 PTH (Bachem,
Torrance, CA, USA) at a rate of 0.022 jtg/hr/100 g body wt using
a subcutaneously implanted miniosmotic pump. To determine the
dose of PTH required to maintain a normal serum calcium level
(9.5 to 10.5 mg/dl), different doses of PTH (0.011, 0.022, 0.044,
0.088 and 0.1 ig/hr/100 g body wt) were evaluated in PTX rats
with normal renal function before the present study; these rats
were fed a 0.6% phosphorus and 0.6% calcium diet. The minios-
motic pumps were filled with rat 1—34 PTH dissolved in isosmotic
saline with 2% cysteine (pH = 1.4). The 0.022 jtg/hr/100 g body wt
dose of PTH produced a normal serum calcium and phosphorus
in PTX rats with normal renal function and was used as the
normal replacement dose for this study.
Rats were housed in individual cages and pair-fed; each rat
received 12 grams of food daily and had free access to water. The
high (1.2%) and moderate (0.6%) phosphorus diets were ob-
tained from ICN (Cleveland, OH, USA) and contained the same
calcium (0.6%), vitamin D (100 lU/lOU g of food) and caloric
content. The study lasted 14 days, during which time the rats
received either the high or moderate phosphorus diets. On day 14
of the study, rats were sacrificed by exanguination after an
overnight fast. Serum samples were frozen at —40°C until bio-
chemical determinations.
Serum calcium, phosphorus, and creatinine were measured with
an autoanalyzer. Serum intact PTH was determined in rats with
intact parathyroid glands using an IRMA assay specific for rats
(Nichols, San Juan Capistrano, CA, USA) with intra- and inter-
assay coefficients of variation of 5.8% and 9%, respectively. With
this assay we were unable to quantify serum PTH in rats receiving
an exogenous PTH infusion. Serum calcitriol was measured using
a radioreceptor assay (Nichols); the intra- and interassay coeffi-
cients of variation were 7.2% and 10.4%, respectively.
Experimental design
Studies in rats on a MPD. In this study, normal rats and rats with
moderate renal failure were maintained on a moderate phospho-
rus diet. The effect that endogenous PTH production had on
serum levels of calcitriol, calcium, and phosphorus was compared
with that of an exogenous normal replacement dose of PTH.
The following groups were evaluated in the first study:
(1.) N-IPTG-MPD: normal (N) rats with intact parathyroid
glands (IPTG) fed a moderate phosphorus diet (MPD -0.6% P,
0.6% Ca).
(2.) N-PTHR-MPD: normal rats which underwent PTX, re-
ceived PTH replacement (PTHR) (0.022 tg/hr/100 g), and were
fed a MPD.
(3.) Nx-IPTG-MPD: nephrectomized (Nx) rats with IPTG fed a
MPD.
(4.) Nx-PTHR-MPD: nephrectomized rats which underwent
PTX, received PTH replacement (0.022 ag/hr/100 g), and were
fed a MPD.
While rats with intact parathyroid glands were expected to show
the normal adaptative response of PTH secretion induced by
renal failure, rats with normal PTH replacement had a fixed
amount of PTH available.
Studies in rats on a HPD. In this study, normal rats and rats with
moderate renal failure were maintained on a high phosphorus
diet. The effect that endogenous PTH secretion had on serum
levels of calcitriol, calcium, and phosphorus was compared with
that of an exogenous replacement dose of PTH.
The following groups were evaluated in the second study:
(1.) N-IPTG-HPD: normal (N) rats with intact parathyroid
glands (IPTG) fed a high phosphorus diet (HPD; 1.2% P, 0.6%
Ca).
(2.) N-PTHR-HPD: normal rats which underwent PTX, re-
ceived PTH replacement (PTHR) (0.022 jig/hr/lOU g), and were
fed a HPD.
(3.) Nx-IPTG-HPD: nephrectomized (Nx) rats with IPTG on a
HPD.
(4.) Nx-PTHR-HPD: nephrectomized rats that underwent
PTX, received a PTH replacement (0.022 jig/hr/lOU g), and were
fed a HPD.
As in the first study, the PTHR rats were parathyroidectomized
and the PTH replacement dose was fixed; thus in these rats, there
was no possibility for the development of secondary hyperpara-
thyroidism in response to the HPD.
Statistics
Results are expressed as the mean standard error (SE).
Comparisons of means from more than two groups were assessed
by ANOVA followed by the Duncan test. Means from two groups
were compared by the unpaired t-test.
Results
The serum creatinine level was similar in all the groups of
normal rats (Table 1). In groups with moderate renal failure,
serum creatinine was greater than in normal rats, but similar
among the groups with renal failure.
Studies in rats on a MPD
As shown in Figure 1, in normal rats on a MPD receiving PTH
replacement (N-PTHR-MPD), serum levels of phosphorus, cal-
cium, and calcitriol were similar to normal rats with intact
parathyroid glands (N-IPTG-MPD). Thus the rate of PTH infu-
sion used in the N-PTHR-MPD group appeared to be the normal
physiologic dose of PTH necessary to maintain normal serum
calcium, phosphorus, and calcitriol levels.
In rats with moderate renal failure fed a MPD, the group with
intact parathyroid glands (Nx-IPTG-MPD) maintained a normal
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Table 1. Biochemical data in normal and azotemic rats
Groups
mg/dl-pg/ml
N-IPTG-MPD
(N = 29)
N-PTHR-MPD
(N = 14)
N-IPTG-HPD
(N = 31)
N-PTHR-HPD
(N = 12)
Phosphorus
PTH
7.1 0.2
40 5 7.7 — 7.8 0.3"67 8" 9.3 0.4"
CTR 69 3" 68 4" 69 4" 56 6
Calcium 10.3 0.1" 10.2 03ad 10.1 0.1=' 8.5 03d
Creatinine 0.26 001d 0.26 0.01" 0.26 0.01" 0.27 0.01"
Groups Nx-IPTG-MPD Nx-PTHR-MPD Nx-IPTG-HPD Nx-PTHR-HPD
mg/dl-pg/ml (N = 18) (N = 12) (N = 16) (N = 13)
Phosphorus
PTH
7.3 0.3""'75 2h 8.5 0.4"— 11.2 0.4286 19 10.8 0.6—
CTR 76 4C 62 4" 68 7" 52 4
Calcium 10.5 0.1""' 8.9 0,2" 8.5 0.2" 6.3 0.2
Creatinine 0.5 0.03 0.5 0.02 0.6 0.02 0.5 0.03
Data are mean SE. N is the number of rats. Abbreviations are: N, normal; Nx, nephrectomized; IPTG, intact parathyroid glands; PTHR, PTH
replacement after parathyroidectomy; MPD, moderate phosphorus diet; HPD, high phosphrous diet.
"P < 0.05 vs PTHR-HPD, same renal function
bP < 0.05 vs IPTG-HPD, same renal function
P < 0.05 vs PTHR-MPD, same renal function
"P < 0.05 vs same Nx group
Fig. 1. Serum (A) phosphorus, (B) calcium, and (C) calcitriol are shown for rats with normal renal function (N) and renal failure (Nx); rats either had intact
parathyroid glands (open bars) or PTXand PTH replacement (0.022 pg/hr/100 g body wt) (gray bars). All rats were fed a moderate phosphorus diet (MPD,
0.6% phosphorus). Values are the mean SE. ap < 0.05 versus intact parathyroid glands and the same renal function; and X < 0.05 versus normal rats
and the same PTH group. Code for Figures 1 through 3: open bars represent rats with intact parathyroid glands; gray bars represent PTX rats with PTH
replacement; cross-hatching represents rats on a high phosphorus diet; and the absence of cross-hatching represents rats on a moderate phosphorus diet.
Symbols for Figs. 1—3 are: (tJ) rats with intact parathyroid glands; (El) PTX rats with PTH replacement; (L2) rats on a high phosphorus diet; and ()
rats on a moderate phosphorus diet.
serum phosphorus; however, the serum phosphorus was increased
(P < 0.001) in rats receiving PTH replacement (Nx-PTHR-MPD)
(Fig. 1). In the PTHR group, the elevation in serum phosphorus
was associated with a decrease in serum calcitriol (62 4 vs. 76
4 pg/mi, P < 0.05) and calcium (8.9 0.2 vs. 10.5 0.1 mg/dl,
P < 0.001). In the Nx-IPTG-MPD group, the PTH level was
increased as compared with the N-IPTG-MPD group (75 12 vs.
40 5 pg/ml, P < 0.05; Table 1).
Studies in rats on a HPD
In normal rats fed a HPD, the serum phosphorus concentration
in rats on PTH replacement (PTHR) was greater than in rats with
intact parathyroid glands (IPTG); (9.3 0,4 vs. 7.8 0.3 mg/di,
P < 0.001; Fig. 2). The hyperphosphatemia in the PTHR group
was associated with a decrease in serum calcitriol (56 6 vs. 69
4 pg/ml, P < 0.05) and hypocalcemia (8.5 0.3 vs. 10.1 0.1
mg/dl, P < 0.001).
In rats with moderate renal failure on a HPD, the serum
phosphorus increased in both the group with intact parathyroid
glands and the group on PTH replacement (Fig. 2). In the PTHR
group, the high serum phosphorus was associated with a marked
decrease in serum caicitriol (52 4 vs. 68 7 pg/ml, P < 0.05)
and calcium (6.3 0.2 vs. 8.5 0.2 mg/dl, P < 0.001) as compared
to the group with intact parathyroid glands. As shown in Table 1,
the serum PTH level in the group with intact parathyroid glands
was markedly increased at 286 19 pg/mt.
Comparisons between normal rats and rats with moderate renal
failure having fixed normal PTH levels
A comparison between the MPD and HPD groups with normal
renal function and PTH replacement (N-PTHR-MPD vs. N-
PTHR-HPD group) is shown in Figure 3. Despite normal renal
function, the serum phosphorus was increased in the HPD group
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Fig. 2. Serum (A') phosphorus, (B) calcium, and (C) calcitriol are shown for rats with normal renal function (N) and renal failure (Nx); rats either had intact
parathyroid glands (white hatched bars) or PTX and PTH replacement (0.022 p.g/hr/100 g body wt) (gray hatched bars). All rats were fed a high phosphorus
diet (HPD, 1.2% phosphorus). Values are the mean SE. P < 0.05 versus intact parathyroid glands and the same renal function; X < 0.05 versus
normal rats and the same PTH group. Symbols are: (LI) rats with intact parathyroid glands; (LI) PTX rats with PTH replacement; (LI) rats on a high
phosphorus diet; and () rats on a moderate phosphorus diet.
Fig. 3. Serum (A) phosphorus, (B) calcium, and (C) calcitriol are shown in rats with normal renal function (N) and renal failure (Nx); rats were fed either
a moderate (gray bars) or a high phosphorus diet (gray hatched bars). All rats had PTX and received PTH replacement at 0.022 pg!hr/100 g body wt. Values
are the mean SE. P < 0.05 versus high phosphorus diet and the same renal function; and X < 0.05 versus normal rats and the same phosphorus diet.
Symbols are: (Lii) rats with intact parathyroid glands; (El) PTX rats with PTH replacement; (Li) rats on a high phosphorus diet; and () rats on a
moderate phosphorus diet.
(P < 0.001). The high serum phosphorus in the HPD group was
also associated with low levels of serum calcitriol and calcium. A
comparison between MPD and HPD groups with moderate renal
failure and PTH replacement (Nx-PTHR-MPD vs. Nx-PTHR-
HPD group) is also shown in Figure 3. The serum phosphorus
level was increased in the two azotemic groups as compared to
their non-azotemic, control groups; the serum phosphorus was
also significantly greater in the HPD than the MPD group (P <
0.001). In rats with moderate renal failure, the HPD also resulted
in lower serum calcitriol (52 4 vs. 62 4 pg/ml, P < 0.05) and
calcium levels (6.3 0.2 vs. 8.9 0.2 mg/dl, P < 0.001) than the
MPD.
Comparisons between normal rats and rats with moderate renal
failure having intact parathyroid glands
As shown in Table 1, the serum level of phosphorus and calcium
was not different between the N-IPTG-HPD and N-IPTG-MPD
groups despite the difference in dietary phosphorus; however, in
the IPTG rats receiving the HPD, the serum PTH level was
increased as compared with rats on a MPD (67 8 vs. 40 5
pg/ml, P < 0.05). In comparison to the Nx-IPTG-MPD group,
serum PTH levels increased fourfold in the Nx-IPTG-HPD group
(75 12 vs. 286 19 pg/mI, P < 0.001).
Discussion
This study shows that in rats with moderate renal failure on a
moderate phosphorus diet, serum calcitriol levels decreased only
if hyperparathyroidism was not allowed to occur. Even in normal
rats, high PTH levels were required to maintain a normal calcitriol
level when rats were fed a high phosphorus diet. Likewise, in rats
with moderate renal failure on a high phosphorus diet, the
development of secondary hyperparathyroidism prevented a de-
crease in serum calcitriol; however, serum calcitriol levels were
low in rats receiving PTH replacement which were deprived of the
adaptative or secondary increase in endogenous PTH.
Phosphorus retention [6, 8, 9, 11, 25, 26] and a calcitriol
deficiency [6, 8, 11, 19, 20, 211 are both important factors which
have been implicated in the development of hyperparathyroidism
in chronic renal failure and their interaction is best studied in
moderate renal failure when significant residual renal mass is
present [7, 8]. In moderate renal failure, phosphorus retention
may contribute to a decrease in calcitriol production; however, if
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secondary hyperparathyroidism is present, the high PTH levels
appear to stimulate the synthesis of calcitriol and counteract the
inhibitory effect of phosphorus. To perform an in vivo study in
which the relative effects of dietary phosphorus and PTH on
calcitriol production are dissociated, it is necessary to separate
changes in PTH induced by dietary phosphorus. The goal of this
study was to evaluate in normal rats and in rats with moderate
renal failure, the relative effect that dietary phosphorus intake and
elevated endogenous PTH levels have on calcitriol production. To
accomplish this goal, we studied normal and azotemic rats with
and without hyperparathyroidism and studied the effect that
differences in dietary phosphorus had on mineral homeostasis [7,
81. To prevent an elevation in serum PTH, rats were parathyroid-
ectomized and PTH was replaced by the continuous infusion of
rat PTH at a dose of 0.022 jig/hr/100 g body wt. In normal rats on
a MPD after PTX, this PTH replacement dose resulted in a
normal serum calcium, phosphorus, and calcitriol level. Thus, this
dose of PTH replacement appeared to be the normal replacement
dose.
In azotemic rats on a MPD, the PTHR group had a higher
serum phosphorus and a lower serum calcitriol level than the
IPTG group. As opposed to the PTHR group in which available
PTH was limited to that infused, the IPTG group developed
significant secondary hyperparathyroidism despite only a moder-
ate load of dietary phosphorus (MPD). These results indicate that
in Nx rats on a MPD, an increase in endogenous PTH may be
necessary to maintain a normal serum calcitriol level.
In normal rats with IPTG on a HPD, serum calcium and
calcitriol were normal, while serum phosphorus and PTH were
minimally increased as a result of dietary phosphorus loading. As
shown in the N-PTHR-HPD group, without this increase in PTH,
normal rats on a HPD would have had a higher serum phosphorus
and low serum calcitriol and calcium levels. This result empha-
sizes that even in the absence of renal failure, the compensatory
increasc in PTH is important for the maintainence of calcium and
phosphorus homeostasis during phosphorus loading. In rats with
moderate renal failure, the HPD produced a marked increase in
serum PTH levels that still failed to maintain normal levels of
serum calcium and phosphorus even though calcitriol levels were
normal. It was likely that the inhibitory effect of phosphorus
accumulation on calcitriol production was counterbalanced by the
stimulatory action of high PTH. While hyperphosphatemia may
not bc commonly observed in patients with moderate renal
failure, our study was intentionally designed to induce marked
hyperphosphatemia to illustrate the fact that in moderate renal
failure a high phosphorus intake may not be followed by a
reduction in serum calcitriol if marked hyperparathyroidism de-
velops. Moreover, our study demonstrates that an elevated PTH
would seem to be responsible for maintaining normal calcitriol
levels since in rats in which secondary hypcrparathyroidism was
prevented, serum calcitriol was markedly decreased. It is possible
that the stimulatory effect of PTH on calcitriol production may be
in part due to its phosphaturic action that would prevent an
excessive increase in serum phosphorus. However, the serum
phosphorus levels were similar in the Nx-IPTG-HPD and the
Nx-PTHR-HPD groups despite the fact that the concentration of
serum calcitriol was greater in the Nx-IPTG-HPD. This result may
have been due to the higher PTH level in the Nx-IPTG-HPD
group. It is also possible that the higher calcitriol level enhanced
the gut absorption of phosphorus and counteracted the phospha-
turic action of PTH. Nonetheless, the higher calcitriol level in the
Nx-IPTG-HPD group would suggest that PTH has a direct
stimulatory effect on calcitriol production that is independent of
phosphorus.
In the absence of endogenous PTH in both normal and
azotemic rats, the HPD resulted in higher serum phosphorus and
lower serum calcitriol levels than the MPD groups. As expected,
the changes in serum phosphorus and calcitriol induced by the
HPD in the PTHR groups were more marked in the azotemic
than the normal group. These results are in agreement with
previous studies which have shown the inhibitory effect of high
dietary phosphorus intake on calcitriol production [6—12]; these
results also serve to illustrate the importance of phosphorus
restriction in the prevention and treatment of secondary hyper-
parathyroidism.
Since hyperparathyroidism is present in moderate renal failure,
it is likely that even a moderate elevation in PTH levels serves to
maintain calcitriol production [8, 9, 16, 19, 21—24]. The fact that
both low and normal levels of calcitriol have been reported in
studies of patients with moderate renal failure may have been due
to differences in the magnitude of hyperparathyroidism and
dietary phosphorus intake [9, 16, 19, 21—24]; our results would
support such an interpretation of these clinical studies. Other
clinical studies also demonstrate the importance of PTH main-
taining a normal serum calcitriol. After uninephrectomy in
healthy kidney donors, a transient fall in calcitriol levels was
observed and this was followed by a subsequent rise to normal
over the following days [17]. This subsequent increase in calcitriol
was accompanied by elevated PTH levels. In patients with primary
hyperparathyroidism, serum calcitriol levels decrease abruptly
from high to normal following removal of the parathyroid ade-
noma [141. Some authors have reported a diminished calcitriol
response to exogenous PTH infusion in patients with moderate
renal failure [10, 15]; however, these patients had normal serum
calcitriol levels and almost a threefold elevation in PTH levels.
Thus, the failure to observe a response to PTH was likely due to
the fact that calcitriol was already stimulated by endogenous PTH
[151. In another report in patients with moderate renal failure,
serum calcitriol levels increased to normal when endogenous PTH
was stimulated [161. Thus, these reports support our findings
which indicate that in rats with moderate renal failure, higher
PTH levels are necessary to maintain the calcitriol production
presumably by increasing calcitriol synthesis per cell.
In conclusion, in normal rats and rats with moderate renal
failure, both phosphorus intake and endogenous PTH separately
modulate ealeitriol production. Furthermore, in uremic rats, high
levels of endogenous PTH maintain caleitriol production and
overcome the inhibitory action of phosphorus retention. Thus, the
high phosphorus diet decreased serum calcitriol levels only when
PTH did not increase. These findings indicate that in moderate
renal failure, elevated PTH levels likely prevent a decrease in
serum ealeitriol.
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